Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Opyl Ltd. ( (AU:OPL) ) has provided an update.
Opyl Limited has appointed Matt Hallam as Chief Revenue Officer to enhance the commercial growth of its core product, TrialKey.ai, in the biopharmaceutical and clinical research sectors. Hallam’s extensive experience in digital health and clinical trials, along with his leadership roles in major healthcare companies, will be pivotal in establishing TrialKey.ai as a leader in AI-driven clinical trial design and feasibility, driving sustainable revenue growth and expanding market presence.
More about Opyl Ltd.
Opyl Limited is an AI company focused on transforming clinical trials and medical research through data and technology. The company is committed to innovation and strategic growth, positioning itself as a leader in the future of healthcare solutions.
Average Trading Volume: 347,687
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.93M
Learn more about OPL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue